Known targets — ChEMBL curated mechanism
ABCC8ACEADORA1ADORA2AADORA2BADORA3ALDH5A1ALOX5ALOX5APATP4AATP4BBRAFCA1CA12CA2CA4CYSLTR1DHFRDPEP1EDNRAEDNRBESR2F10FDPSFGF1GABBR1GABBR2GABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGARTGNRHRGSC1HMGCRIMPDH1IMPDH2KCNJ11LY96NOD2NR3C1NS3NS4ANS5bP2RY1P2RY12P2RY2P2RY4P2RY6PBP2XPDE3APDE3BPDE4APDE4BPDE4CPDE4DPDK1PDK2PDK3PDK4PPARGPPATPTGIRPTGS1PTGS2RAF1RYR1RYR3SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASERPINC1SLC12A1SLC12A3SYKTHRATHRBTLR3TLR4TLR9TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYMSVKORC1XDHblablaIMP-1blaOXA-33blaOXA-58blaT-3blaT-4blaT-5blaT-6dacAdacBdacCfolAfolPfolP1ftsIfusAgaggyrAgyrBmecAmrcAmrcBmrdApbp1apbp1bpbp2pbp2apbp2bpbp3pbp4pbpApbpBpbpCpbpFpolponBrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpoArpoBrpoCrpoZrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | THRB known ✓ | P10828 | 2/20 | 1.00 |
| ▸ | CA12 known ✓ | O43570 | 2/20 | 0.36 |
| ▸ | CA2 known ✓ | P00918 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 1.00 |
| ▸ | HIF1A | Q16665 | 2/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | ALOX15 | P16050 | 1/20 | 1.00 |
| ▸ | ALOX12 | P18054 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | RECQL | P46063 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 1.00 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 1.00 |
| ▸ | APP | P05067 | 1/20 | 0.56 |
| ▸ | PTPN1 | P18031 | 4/20 | 0.52 |
| ▸ | USP2 | O75604 | 1/20 | 0.52 |
| ▸ | ATM | Q13315 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29568770 | 0.93 | THRB (0.86) | THRBALDH1A1HIF1ACYP3A4ALOX15 | |
| SCHEMBL29637843 | 0.92 | THRB (0.85) | THRBALDH1A1HIF1ACYP3A4ALOX15 | |
| SCHEMBL29482552 | 0.87 | ALDH1A1 (0.78) | THRBALDH1A1HIF1ACYP3A4ALOX15 | |
| SCHEMBL29390387 | 0.87 | MAPK1 (0.77) | THRBALDH1A1HIF1ACYP3A4ALOX15 | |
| SCHEMBL29438532 | 0.78 | APP (0.66) | THRBALDH1A1HIF1ACYP3A4ALOX15 | |
| SCHEMBL18084213 | 0.75 | ALDH1A1 (0.60) | THRBALDH1A1HIF1ACYP3A4ALOX15 | |
| SCHEMBL185277 | 0.74 | APP (0.98) | THRBALDH1A1HIF1ACYP3A4ALOX15 | |
| SCHEMBL29678237 | 0.74 | ALDH1A1 (0.59) | THRBALDH1A1HIF1ACYP3A4ALOX15 | |
| Orange G SCHEMBL81967 | 0.73 | APP (1.00) | THRBALDH1A1HIF1ACYP3A4ALOX15 | |
| Orange G SCHEMBL29369740 | 0.73 | APP (1.00) | THRBALDH1A1HIF1ACYP3A4ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 139 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4692249-A1 | COLORING AGENT, COLORING COMPOSITION, AND METHOD FOR PRODUCING COLORING AGENT | Artience Co., Ltd. (JP) | 2026-02-11 | — | — | EP | claimed |
| US-12130267-B2 | Analyzing method for azo compound | SHIMADZU CORPORATION (JP) | 2024-10-29 | — | — | US | claimed |
| WO-2024204597-A1 | COLORING AGENT, COLORING COMPOSITION, AND METHOD FOR PRODUCING COLORING AGENT | ａｒｔｉｅｎｃｅ株式会社 | 2024-10-03 | — | — | WO | claimed |
| EP-4160211-A1 | DETECTING THE EXPOSURE OF A SUBJECT TO A THYROID DISRUPTING CHEMICAL, EVEN BEFORE HYPOTHYROIDISM APPEARS | Moreno Navarro, José Carlos (ES) | 2023-04-05 | — | — | EP | claimed |
| CN-114716845-A | Acidic ink-jet digital printing ink, preparation method and application | 青岛英杰泰新材料有限公司 | 2022-07-08 | — | — | CN | claimed |
| CN-114371244-A | Quality control method for banned azo dye detection of textile | 中纺标检验认证股份有限公司 | 2022-04-19 | — | — | CN | claimed |
| EP-3980140-A2 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | FRS Group, LLC (US) | 2022-04-13 | — | — | EP | claimed |
| US-20220026404-A1 | ANALYZING METHOD FOR AZO COMPOUND | SHIMADZU CORPORATION (JP) | 2022-01-27 | — | — | US | claimed |
| US-12629555-B2 | Long-term fire retardant with magnesium sulfate and corrosion inhibitors and methods for making and using same | PERIMETER SOLUTIONS, LP (US) | 2026-05-19 | — | — | US | disclosed |
| EP-4731312-A1 | SYSTEMS, APPARATUS, AND METHODS FOR DILUTION AND EFFECTIVE MIXING OF HIGH VISCOSITY LONG-TERM FIRE RETARDANT LIQUID CONCENTRATES | Perimeter Solutions LP (US) | 2026-04-29 | — | — | EP | disclosed |
| EP-4703437-A1 | ULTRAVIOLET-CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, CURED PRODUCT, ULTRAVIOLET-CURABLE INK, METHOD FOR PRODUCING PRINTED MATTER, AND PRINTED MATTER | Mitsubishi Chemical Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4703438-A1 | ULTRAVIOLET-CURABLE COMPOSITION, METHOD FOR PRODUCING CURED PRODUCT, CURED PRODUCT, ULTRAVIOLET-CURABLE INK, METHOD FOR PRODUCING PRINTED MATTER, AND PRINTED MATTER | Mitsubishi Chemical Corporation (JP) | 2026-03-04 | — | — | EP | disclosed |
| EP-4692249-A1 | COLORING AGENT, COLORING COMPOSITION, AND METHOD FOR PRODUCING COLORING AGENT | Artience Co., Ltd. (JP) | 2026-02-11 | — | — | EP | disclosed |
| US-20260014404-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | PERIMETER SOLUTIONS, LP (US) | 2026-01-15 | — | — | US | disclosed |
| CN-114371244-A | Quality control method for banned azo dye detection of textile | 中纺标检验认证股份有限公司 | 2022-04-19 | — | — | CN | disclosed |
| EP-3980140-A2 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | FRS Group, LLC (US) | 2022-04-13 | — | — | EP | disclosed |
| CN-110337454-B | Water-soluble composition, method for producing cured product thereof, and acylphosphinate | 株式会社ADEKA | 2022-04-12 | — | — | CN | disclosed |
| US-20220080242-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2022-03-17 | — | — | US | disclosed |
| US-20220072355-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | U.S. BANK TRUST COMPANY, NATIONAL ASSOCIATION, AS NOTES COLLATERAL AGENT | 2022-03-10 | — | — | US | disclosed |
| US-20220026404-A1 | ANALYZING METHOD FOR AZO COMPOUND | SHIMADZU CORPORATION (JP) | 2022-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12629555-B2 | Long-term fire retardant with magnesium sulfate and corrosion inhibitors and methods for making and using same | SLC6A12, SLC9A2, SLC11A2 | THRB 1787/4885CA12 247/4885CA2 13/4885 |
| US-20260014404-A1 | LONG-TERM FIRE RETARDANT WITH CORROSION INHIBITORS AND METHODS FOR MAKING AND USING SAME | SLC6A12, SLC11A2, KCNN1 | THRB 1011/4885CA12 355/4885CA2 23/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.